intramuscular route: count injections given Visit 3 (week 26) Anamnesis: record lifestyle habits and use of alcohol Symptoms: if pathological at the first visit, record paresthesia, asthenia, loss or reduction of appetite, sadness or change in level of happiness, and concomitant pharmacological treatment Physical examination: if pathological at the first visit examine for Hunters glositis, positional and vibrational sensitivity Record concomitant treatment Request analyses to be performed one week before next visit: haemogram and serum vitamin B12 Questionnaire: EuroQoL-5D Assessment of adverse effects Therapeutic plan: patient in oral arm provision of medication
Instead of one 8mg injection weekly, try two 4mg injections spaced 3-4 days apart (for example, Monday and Thursday)
Dissolved AHK-Cu in solution degrades faster than powder
Every supporting citation is single-compound
Recalls & Warnings September 12, 2018 FDA Urges Consumers to Avoid Kratom On September 11, 2018, FDA Commissioner Scott Gottlieb, M.D., urged consumers not to use products containing the kratom, an herb that is often promoted for pain relief and for relieving symptoms of opioid withdrawal
